Survival Contract Clauses (6,236)

Grouped Into 200 Collections of Similar Clauses From Business Contracts

This page contains Survival clauses in business contracts and legal agreements. We have organized these clauses into groups of similarly worded clauses.
Survival. Executive's post-termination obligations and the Company Group's post- termination rights under Sections 6 through 19 of this Agreement shall survive the termination of this Agreement and the termination of Executive's employment with the Company regardless of the reason for termination, including upon expiration of the Employment Term; shall continue in full force and effect in accordance with their terms; and shall continue to be binding on the parties. 14 20. Independent Advice. Executive ack...nowledges that the Company has provided Executive with a reasonable opportunity to obtain independent legal advice with respect to this Agreement and, particularly, to understand and acknowledge the restrictions being placed on Executive pursuant to Sections 6-13 of this Agreement, and that Executive has had such independent legal advice prior to executing this Agreement. View More
Survival. The Executive's post-termination rights and obligations and the Company Group's post- termination post-termination rights and obligations under Sections 6 4 through 19 26 of this Agreement shall survive the termination of this Agreement and the termination of the Executive's employment with the Company regardless of the reason for termination, including upon expiration of the Employment Term; termination; shall continue in full force and effect in accordance with their terms; and shall continue ...to be binding on the parties. 14 Parties. 16 20. Independent Advice. The Executive acknowledges that the Company has provided the Executive with a reasonable opportunity to obtain independent legal advice with respect to this Agreement and, particularly, to understand and acknowledge the restrictions being placed on Executive pursuant to Sections 6-13 of this Agreement, and that either: (a) the Executive has had such independent legal advice prior to executing this Agreement. Agreement; or (b) the Executive has willingly chosen not to obtain such advice and to execute this Agreement without having obtained such advice. View More
Survival. Executive's post-termination obligations and the Company Group's post- termination post-termination rights under Sections 6 8 through 19 of this Agreement and the obligations of the Company Group under Sections 3(f) and (g) and Sections 5 through 7 shall survive the termination of this Agreement and the termination of Executive's employment with the Company regardless of the reason for termination, including upon expiration of the Employment Term; termination; shall continue in full force and ef...fect in accordance with their terms; and shall continue to be binding on the parties. 14 20. 18 22. Independent Advice. Executive acknowledges that the Company has provided Executive with a reasonable opportunity to obtain independent legal advice with respect to this Agreement and, particularly, to understand and acknowledge the restrictions being placed on Executive pursuant to Sections 6-13 8-15 of this Agreement, and that Executive has had such independent legal advice prior to executing this Agreement. View More
View Variations (2)
Survival. This Agreement (a) shall survive my employment by Company; (b) does not in any way restrict my right to resign or the right of Company to terminate my employment at any time, for any reason or for no reason; (c) inures to the benefit of successors and assigns of Company; and (d) is binding upon my heirs and legal representatives.
Survival. This Agreement (a) shall survive my employment by Company; Company, (b) does not in any way restrict my right to resign or the right of Company to terminate my employment at any time, for any reason or for no reason; reason, and (c) inures to the benefit of and is binding on successors and assigns of Company; Company, and (d) is binding upon my heirs and legal representatives.
View Variations (2)
Survival. The provisions of Sections 4 through 20 shall survive the expiration or earlier termination of the Term.
Survival. The provisions of Sections 4 through 20 shall survive the expiration or earlier termination of the Term. this Agreement.
Survival. The provisions of Section 3.5 and Sections 4 through 20 shall survive the expiration or earlier termination of the Term. this Agreement.
View Variations (2)
Survival. This Section 14 and the covenants and agreements contained in Sections 4, 6, 7, and 8 of this Agreement shall survive termination of this Agreement and Executive's employment.
Survival. This Section 14 and the covenants and agreements contained in Sections 4, 6, 7, and 8 of this Agreement shall survive termination of this Agreement and Executive's employment.
Survival. This Section 14 and the covenants and agreements contained in Sections 3, 4, 6, 7, and 8 of this Agreement shall survive termination of this Agreement and Executive's employment.
View Variations (2)
Survival. The provisions of Sections 5, 6, 7, 8, 9, and 11 through 17 shall survive the termination of this Grant and of this Agreement.
Survival. The provisions of Sections 5, 6, 7, 8, 9, and 11 through 17 19 shall survive the termination of this Grant and of this Agreement.
Survival. The provisions of Sections 5, 6, 7, 8, 9, and 11 through 17 shall survive the termination of this Grant and of this Agreement.
View Variations (2)
Survival. The provisions of Section 4, Section 5, Section 6, Section 7, Section 9, Section 10, Section 11, this Section 16, Section 18 and Section 19 shall survive any termination or expiration of this Agreement.
Survival. The provisions of Section 4, Section 5, Section 6, Section 7, this Section 9, 8, Section 10, Section 11, this 15, Section 16, Section 18 17 and Section 19 18 of this Agreement shall survive any the termination or expiration of this Agreement.
Survival. The provisions of Section 4, Section 5, Section 6, Section 7, Section 9, Section 10, Section 11, this Section 16, Section 18 and Section 19 shall survive any termination or expiration of this Agreement.
View Variations (2)
Survival. The provisions of Sections 5 through 24 of this Agreement shall survive the term of this Agreement and the termination of the Executive's employment with the Company, and shall continue thereafter in full force and effect in accordance with their terms.
Survival. The provisions of Sections 5 through 24 25 of this Agreement shall survive the term of this Agreement and the termination of the Executive's employment with the Company, and shall continue thereafter in full force and effect in accordance with their terms.
Survival. The provisions of Sections 5 through 24 and 6 of this Agreement shall survive the term of this Agreement and the termination of the Executive's employment with the Company, and shall continue thereafter in full force and effect in accordance with their terms.
View Variations (2)
Survival. The covenants, agreements, representations and warranties contained in or made in Sections 7 through 22 of this Agreement shall survive any termination of the Executive's employment.
Survival. The covenants, agreements, representations and warranties contained in or made in Sections 7 through 22 of this Agreement shall survive any termination of the Executive's employment.
View Variations (2)
Survival. (a) The obligations of the parties to pay any costs and expenses hereunder and to provide indemnification and contribution as provided herein shall survive any termination hereunder. In addition, the provisions of Sections 3(d), and 8 through 16 shall survive the sale of the Units or any termination of the Offering hereunder. (b) The respective indemnities, covenants, representations, warranties and other statements of Issuer, JBT and the Placement Agent set forth in or made pursuant to this Agr...eement will remain in full force and effect, regardless of any investigation made by or on behalf of, and regardless of any access to information by, Issuer, JBT or the Placement Agent, or any of their officers or directors or any controlling person thereof, and will survive the sale of the Units or any termination of the Offering hereunder for a period of four years from the earlier to occur of the Final Closing or the termination of the Offering. 28 12. Notices. All notices and other communications given or made pursuant hereto shall be in writing and shall be deemed to have been duly given or made as of the date delivered personally, or the date mailed if mailed by registered or certified mail (postage prepaid, return receipt requested) to the parties at the following addresses (or at such other address for a party as shall be specified by like changes of address which shall be effective upon receipt) or sent by facsimile transmission, with confirmation received, if sent to the Placement Agent, will be mailed, delivered or telefaxed and confirmed to Aegis Capital Corp., 810 Seventh Ave, 11th Floor, New York, New York 10019, Attention: Adam K. Stern, telefax number (646) 390-9122, with a copy (which shall not constitute notice) to: Littman Krooks LLP, 655 Third Avenue, 20th floor New York, NY 10017 Attention: Steven D. Uslaner, Esq., telefax number (212) 490-2990, if sent to JBT or the Company, will be mailed, delivered or telefaxed and confirmed to JB Therapeutics, Inc., One Kendall Square, Bldg 200, Cambridge, MA 02139, Attn: Yuval Cohen, CEO, with a copy (which shall not constitute notice) to: Lowenstein Sandler LLP, 1251 Avenue of the Americas, New York, NY 10020, Attn: Steven M. Skolnick, Esq., telefax number (973) 597 2477, and if sent to Issuer, will be mailed, delivered or telefaxed and confirmed to Corbus Pharmaceuticals Holdings, Inc., 142 West 57th St. Suite 4A, New York, NY 10019, Attn: David Hochman, President, with a copy (which shall not constitute notice) to: Meister Selig & Fein LLP, Two Grand Central Tower, 140 East 45th Street, 19th Floor, New York, NY 10017, Attn: Kenneth S. Goodwin, Esq., provided, however, that from and after the First Closing, notices to Issuer shall be sent in the same manner, and to the same address, as notices to JBT, with a copy (which shall not constitute notice) to: Lowenstein Sandler LLP, 1251 Avenue of the Americas, New York, NY 10020, Attn: Steven M. Skolnick, Esq., telefax number (973) 597 2477. View More
Survival. (a) The obligations of the parties to pay any costs and expenses hereunder and to provide indemnification and contribution as provided herein shall survive any termination hereunder. In addition, the provisions of Sections 3(d), 3(f) (only following a termination after the First Closing) and 8 through 16 shall survive the sale of the Units or any termination of the Offering hereunder. (b) The respective indemnities, covenants, representations, warranties and other statements of Issuer, JBT OPCO ...and the Placement Agent set forth in or made pursuant to this Agreement will remain in full force and effect, regardless of any investigation made by or on behalf of, and regardless of any access to information by, Issuer, JBT OPCO or the Placement Agent, or any of their officers or directors or any controlling person thereof, and will survive the sale of the Units or any termination of the Offering hereunder for a period of four two (2) years from the earlier to occur of the Final Closing or the termination of the Offering. 28 30 12. Notices. All notices and other communications given or made pursuant hereto shall be in writing and shall be deemed to have been duly given or made as of the date delivered personally, or the date mailed if mailed by registered or certified mail (postage prepaid, return receipt requested) to the parties at the following addresses (or at such other address for a party as shall be specified by like changes of address which shall be effective upon receipt) or sent by facsimile transmission, with confirmation received, if sent to the Placement Agent, will be mailed, delivered or telefaxed and confirmed to Aegis Capital Corp., 810 Seventh Ave, 11th Floor, New York, New York 10019, Attention: Adam K. Stern, telefax number (646) 390-9122, with a copy (which shall not constitute notice) to: Littman Krooks LLP, 655 Third Avenue, 20th floor floor, New York, NY 10017 Attention: Steven D. Uslaner, Esq., telefax number (212) 490-2990, if sent to JBT or the Company, OPCO, will be mailed, delivered or telefaxed and confirmed to JB Therapeutics, Adgero Biopharmaceuticals, Inc., One Kendall Square, Bldg 200, Cambridge, MA 02139, Attn: Yuval Cohen, CEO, 301 N. Harrison St., Suite 9F #459, Princeton, NJ 08540, Attention: Frank Pilkiewicz, CEO with a copy (which shall not constitute notice) to: Lowenstein Sandler LLP, 1251 Avenue of the Americas, New York, NY 10020, Attn: Steven M. Skolnick, Esq., telefax number (973) 597 2477, and if sent to Issuer, will be mailed, delivered or telefaxed and confirmed to Corbus Pharmaceuticals Adgero Biopharmaceuticals Holdings, Inc., 142 West 57th St. 60 East 42nd Street, Suite 4A, 1160, New York, NY 10019, 10165, Attn: David Hochman, President, with a copy (which shall not constitute notice) to: Meister Selig & Fein LLP, Two Grand Central Tower, 140 East 45th Street, 19th Floor, 121 Park Avenue, 7th floor, New York, NY 10017, Attn: Kenneth S. Goodwin, Esq., provided, however, that from and after the First Closing, notices to Issuer shall be sent in the same manner, and to the same address, as notices to JBT, OPCO, with a copy (which shall not constitute notice) to: Lowenstein Sandler LLP, 1251 Avenue of the Americas, New York, NY 10020, Attn: Steven M. Skolnick, Esq., telefax number (973) 597 2477. 597-2477. View More
Survival. (a) The obligations of the parties to pay any costs and expenses hereunder and to provide indemnification and contribution as provided herein shall survive any termination hereunder. In addition, the provisions of Sections 3(d), and 8 through 16 shall survive the sale of the Units or any termination of the Offering hereunder. (b) The respective indemnities, covenants, representations, warranties and other statements of Issuer, JBT Newco, Matinas and the Placement Agent set forth in or made pursu...ant to this Agreement will remain in full force and effect, regardless of any investigation made by or on behalf of, and regardless of any access to information by, Issuer, JBT Newco, Matinas or the Placement Agent, or any of their officers or directors or any controlling person thereof, and will survive the sale of the Units or any termination of the Offering hereunder for a period of four years from the earlier to occur of the Final Closing or the termination of the Offering. 28 26 12. Notices. All notices and other communications given or made pursuant hereto shall be in writing and shall be deemed to have been duly given or made as of the date delivered personally, or the date mailed if mailed by registered or certified mail (postage prepaid, return receipt requested) to the parties at the following addresses (or at such other address for a party as shall be specified by like changes of address which shall be effective upon receipt) or sent by facsimile transmission, with confirmation received, if sent to the Placement Agent, will be mailed, delivered or telefaxed and confirmed to Aegis Capital Corp., 810 Seventh Ave, 11th Floor, New York, New York 10019, Attention: Adam K. Stern, telefax number (646) 390-9122, with a copy (which shall not constitute notice) to: Littman Krooks Meister Selig & Fein LLP, 655 Third Avenue, 20th floor Two Grand Central Tower, 140 East 45th Street, 19th Floor, New York, NY 10017 Attention: Steven D. Uslaner, 10017, Attn: Kenneth S. Goodwin, Esq., telefax number (212) 490-2990, 655-3535, if sent to JBT Matinas or the Company, will be mailed, delivered or telefaxed and confirmed to JB Therapeutics, Matinas BioPharma, Inc., One Kendall Square, Bldg 200, Cambridge, MA 02139, 915 Klosterman Road East, Tarpon Springs, FL 34689, Attn: Yuval Cohen, Roelof Rongen, President & CEO, with a copy (which shall not constitute notice) to: Lowenstein Sandler LLP, 1251 Avenue of the Americas, New York, NY 10020, Attn: Steven M. Skolnick, Esq., telefax number (973) 597 2477, and if sent to Issuer, Newco, will be mailed, delivered or telefaxed and confirmed to Corbus Pharmaceuticals Matinas BioPharma Holdings, Inc., 142 West 57th St. 600 W. Germantown Pike, Suite 4A, New York, NY 10019, 400, Plymouth Meeting, PA 19462, Attn: David Hochman, Stephen P. Harrington, President, with a copy (which shall not constitute notice) to: Meister Selig & Fein LLP, Two Grand Central Tower, 140 East 45th Street, 19th Floor, New York, NY 10017, Attn: Kenneth S. Goodwin, Esq., provided, however, hower, that from and after the First Closing, notices to Issuer Newco shall be sent in the same manner, and to the same address, as notices to JBT, Matinas, with a copy (which shall not constitute notice) to: Lowenstein Sandler LLP, 1251 Avenue of the Americas, New York, NY 10020, Attn: Steven M. Skolnick, Esq., telefax number (973) 597 2477. View More
View Variations (2)
Survival. The obligations contained in this Agreement shall survive the termination of Employee's employment with Employer or expiration of this Agreement as necessary to carry out the intentions of the parties as described herein.
Survival. The obligations contained in this Agreement shall survive the termination of Employee's Executive's employment with Employer or the expiration or termination of this Agreement as necessary to carry out the intentions of the parties as described herein.
View Variations (2)